Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 117675
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.117675
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.117675
Table 1 Types and sources of stem cells used in head and neck reconstruction
| Stem cell type | Source tissue | Main clinical application | Delivery method | Key regenerative mechanism |
| Bone marrow-derived mesenchymal stem cells (BM-MSCs) | Iliac crest, long bones | Mandibular bone regeneration, osteoradionecrosis, vascularized flap enhancement | Local injection, scaffold seeding, or infusion during reconstruction | Osteogenic differentiation; secretion of VEGF, PDGF, and IL-10 promoting angiogenesis and anti-inflammatory effects |
| Adipose-derived stem cells (ADSCs) | Subcutaneous adipose tissue | Soft tissue augmentation, post-radiation fibrosis repair, contour restoration | Fat graft enrichment, injection, or matrix incorporation | Paracrine secretion of growth factors enhancing angiogenesis and collagen remodeling |
| Dental pulp and periodontal ligament stem cells (DPSCs/PDLSCs) | Extracted teeth, periodontal ligament | Craniofacial bone and dental tissue regeneration | Scaffold-based implantation or hydrogel encapsulation | Osteogenic and neurogenic differentiation; ECM deposition |
| Salivary gland progenitor/stem cells | Submandibular or parotid gland tissue | Radiation-induced xerostomia, salivary gland dysfunction | Autologous isolation, ex vivo expansion, and reinfusion post-radiotherapy | Acinar and ductal cell regeneration; revascularization of glandular tissue |
| Induced pluripotent stem cells (iPSCs) | Reprogrammed somatic cells (skin fibroblasts, blood cells) | Customized bone and mucosal reconstruction; tissue engineering | Scaffold seeding, 3D bioprinting, or pre-differentiation into osteoblasts and chondrocytes | High differentiation capacity enabling patient-specific tissue formation |
| Allogeneic MSCs (umbilical cord, Wharton’s jelly, placenta) | Postnatal tissues | Alternative source when an autologous harvest is not feasible | Intralesional injection or scaffold integration | Immunomodulation and trophic signaling with low immunogenicity |
- Citation: Zeppieri M, Capobianco M, Visalli F, Khouyyi M, Gagliano C, Cappellani F, Robiony M, Tel A, Michelutti L. Stem cell transplantation in head and neck oncology: Integrating oncologic treatment and maxillofacial reconstruction. World J Transplant 2026; 16(2): 117675
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/117675.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.117675